SARS-CoV-2 has infected over 340 million people, prompting therapeutic research. While
genetic studies can highlight potential drug targets, understanding the heritability of SARS …

Multiple COVID-19 genome-wide association studies (GWASs) have identified reproducible
genetic associations indicating that there is a genetic component to susceptibility and …

The host response to SARS-CoV-2, the etiologic agent of the COVID-19 pandemic,
demonstrates significant interindividual variability. In addition to showing more disease in …

COVID-19 presents with a wide range of severity, from asymptomatic in some individuals to
fatal in others. Based on a study of over one million 23andMe research participants, we …

Background The emergence of the novel coronavirus in Wuhan, Hubei Province, China, in
December 2019 marked the synchronization of the world to a peculiar clock that is counting …

COVID-19 presents with a wide range of severity, from asymptomatic in some individuals to
fatal in others. Based on a study of 1,051,032 23andMe research participants, we report …

Background COVID-19 manifests with huge heterogeneity in susceptibility and severity
outcomes. UK Black Asian and Minority Ethnic (BAME) groups have demonstrated …

The COVID-19 pandemic has spawned global health crisis of unprecedented magnitude,
claiming millions of lives and pushing healthcare systems in many countries to the brink …

Human genetics can inform the biology and epidemiology of coronavirus disease 2019
(COVID-19) by pinpointing causal mechanisms that explain why some individuals become …

Controlling the SARS-CoV-2 pandemic becomes increasingly challenging as the virus
adapts to human hosts through the continual emergence of more transmissible variants …